This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cory, J. G. Articles by Carter, G. L. Search for Related Content PubMed PubMed Citation Articles by Cory, J. G. Articles by Carter, G. L.

Effect of 5-Fluorouracil on RNA Metabolism in Novikoff Hepatoma Cells¹

Department of Biochemistry, College of Medicine, University of South Florida, Tampa, Florida 33612

The resistance of a Novikoff hepatoma cell line (N1-S1/FdUrd) to 5-fluorouracil (FUra) was reversed by the inclusion of inosine in the culture medium. As the concentration of inosine in the medium was increased, there was a marked increase in the uptake of [¹⁴C]FUra and conversion to nucleotides with a corresponding increase in the incorporation into RNA. While FUra alone had no effect on this resistant cell line, the combination of FUra plus inosine altered the levels of ribose 1-phosphate but not 5-phosphoribosyl 1-pyrophosphate, altered the maturation of precursor ribosomal RNA by blocking the formation of 18S RNA, altered the methylation of the ribosomal RNA, and caused inhibition of the growth of these cells. No evidence was obtained that fluorodeoxyuridine 5'-monophosphate was formed in the N1-S1/FdUrd cells as a result of treatment with FUra plus inosine. In addition, the metabolism of [³H]deoxycytidine in the presence of FUra plus inosine in the intact N1-S1/FdUrd cells did not indicate significant inhibition of thymidylate synthetase as evidenced by the levels of deoxyuridine 5'-monophosphate or conversion to thymidine 5'-monophosphate.

¹ This study was supported by Grant CA-14762 from the National Cancer Institute, USPHS.

² To whom requests for reprints should be addressed.

Received 5/17/79. Accepted 9/ 6/79.

This article has been cited by other articles:

				J. R. Brody, T. Hucl, C. L. Costantino, J. R. Eshleman, E. Gallmeier, H. Zhu, M. S. van der Heijden, J. M. Winter, A. K. Wikiewicz, C. J. Yeo, et al. Limits to Thymidylate Synthase and TP53 Genes as Predictive Determinants for Fluoropyrimidine Sensitivity and Further Evidence for RNA-Based Toxicity as a Major Influence Cancer Res., February 1, 2009; 69(3): 984 - 991. [Abstract] [Full Text] [PDF]

				S. Kammler, S. Lykke-Andersen, and T. H. Jensen The RNA Exosome Component hRrp6 Is a Target for 5-Fluorouracil in Human Cells Mol. Cancer Res., June 1, 2008; 6(6): 990 - 995. [Abstract] [Full Text] [PDF]

				X. Zhao and Y.-T. Yu Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo Nucleic Acids Res., January 28, 2007; 35(2): 550 - 558. [Abstract] [Full Text] [PDF]

				F. Fang, J. Hoskins, and J. S. Butler 5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs Mol. Cell. Biol., December 15, 2004; 24(24): 10766 - 10776. [Abstract] [Full Text] [PDF]